Pfizer Change in Accounts Payable 2010-2025 | PFE
Pfizer annual/quarterly change in accounts payable history and growth rate from 2010 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- Pfizer change in accounts payable for the quarter ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Pfizer change in accounts payable for the twelve months ending June 30, 2025 was $0M, a 0% increase year-over-year.
- Pfizer annual change in accounts payable for 2024 was $0B, a 0% decline from 2023.
- Pfizer annual change in accounts payable for 2023 was $0B, a 0% decline from 2022.
- Pfizer annual change in accounts payable for 2022 was $0B, a 0% decline from 2021.
Pfizer Annual Change in Accounts Payable
(Millions of US $) |
| 2024 |
$N/A |
| 2023 |
$N/A |
| 2022 |
$N/A |
| 2021 |
$N/A |
| 2020 |
$N/A |
| 2019 |
$N/A |
| 2018 |
$N/A |
| 2017 |
$N/A |
| 2016 |
$N/A |
| 2015 |
$N/A |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$N/A |
| 2011 |
$N/A |
| 2010 |
$N/A |
| 2009 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Large Cap Pharmaceutical |
$141.684B |
$63.627B |
|
Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare Disease, Hospital, Vaccines and Internal Medicine. Pfizer spinned-off its Upjohn unit, its off-patent branded and generic established medicines business, and combined it with generic drugmaker Mylan to create a new generic pharmaceutical company called Viatris. The Consumer Healthcare (CHC) segment, an over-the-counter (OTC) medicines business, was merged with Glaxo's unit to form a new joint venture.?The Consumer Healthcare joint venture with Glaxo and the merger of Upjohn unit with Mylan has made Pfizer a smaller company with a diversified portfolio of innovative drugs and vaccines.
|
